Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Nature Medicine2013Vol. 19(3), pp. 368–371
Citations Over TimeTop 1% of 2013 papers
Gannie Tzoneva, Arianne Pérez-García, Zachary Carpenter, Hossein Khiabanian, Valeria Tosello, Maddalena Allegretta, Elisabeth Paietta, Janis Racevskis, Jacob M. Rowe, Martin S. Tallman, Maddalena Paganin, Giuseppe Basso, Jana Hof, Renate Kirschner‐Schwabe, Teresa Palomero, Raúl Rabadán, Adolfo A. Ferrando
Related Papers
- → Contribution of cytosolic and membrane-bound 5'-nucleotidases to cardiac adenosine production(1996)28 cited
- → The soluble ‘low-Km’ 5′-nucleotidase of rat kidney represents solubilized ecto-5′-nucleotidase(1991)23 cited
- → Immunogold localization of adenosine 5'-monophosphate-specific cytosolic 5'-nucleotidase in dog heart.(1993)9 cited
- → Enhancement of 5′-nucleotidase activity of human leukemic cells after fractionation: implications for cancer and aging(1989)3 cited
- Uptake of free adenosine and adenosine from adenosine monophosphate by human peripheral blood lymphocytes: possible kinetic role for ecto-5'-nucleotidase in the regulation of intracellular adenosine.(1986)